About 1 result found for searched term "Lorigerlimab" (0.129 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25134 | Lorigerlimab | PD-1/PD-L1 |
| MGD019 | ||
| Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
